Beth Bhatt

Beth Bhatt focuses on hereditary ovarian cancer prevention and management, particularly in BRCA1 and BRCA2 mutation carriers. Her research has characterized the timing and outcomes of risk-reducing salpingo-oophorectomy and its impact on ovarian cancer prevention and surgical menopause. She has studied the emerging understanding that most BRCA-related ovarian cancers arise in the fallopian tube from serous tubal intraepithelial carcinoma (STIC) lesions. Her translational work informs guidelines for genetic testing, surveillance, and prevention in high-risk women.